Showing results (81-90 of 152) with videos related to
Sort By:
Pageof 16
Pharmacopsychiatry|June 6, 2013
Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate propertiesD Holthoewer, K M Kirschbaum, J Frisch, et al.Clinical Neuropharmacology|May 14, 1998
Interaction of modafinil and clomipramine as comedication in a narcoleptic patientM Grözinger, S Härtter, C Hiemke, et al.Psychiatric Genetics|September 20, 2000
Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association studyC Fehr, A Szegedi, I Anghelescu, et al.Pharmacopsychiatry|January 6, 2011
Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatientsV Stieffenhofer, H Saglam, I Schmidtmann, et al.Psychopharmacology|April 1, 1996
Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECTS Schlegel, R Schlösser, C Hiemke, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|August 11, 1998
Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of carbamazepine and its main metabolitesS Härtter, B Jensen, C Hiemke, et al.Pharmacopsychiatry|October 1, 2011
Therapeutic drug monitoring in Italian psychiatryA Conca, E Schmidt, M Pastore, et al.Neuroendocrinology|March 21, 1998
Effects of pulsed high-frequency electromagnetic fields on the neuroendocrine systemK Mann, P Wagner, G Brunn, et al.Pharmacopsychiatry|September 4, 2015
Retrospective pilot study for analysis of antidepressant serum concentrations of citalopram and venlafaxine during inflammationG Hefner, M E E Shams, S Unterecker, et al.Therapeutic Drug Monitoring|July 31, 2001
Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring serviceH Weigmann, S Gerek, A Zeisig, et al.Pageof 16